Participant Safety

CCCT considers your safety a top priority. We ensure that all members of the CCCT staff follow ethical and Good Clinical Practice guidelines. We guarantee that all patient information is kept confidential and is safeguarded. Each patient is given an identification number for the study he or she is enrolled in so that all personal and medical information remains anonymous.

Clinical trials conducted at our sites follow study protocols closely, and progress reports are completed consistently during trials. The Institutional Review Board (IRB), a group of physicians and community advocates, is set in place to further protect the welfare and rights of participants. The IRB is authorized by the Food and Drug Administration (FDA) and the Department of Health and Human Services (DHHS) to accept, modify, or disapprove upcoming or ongoing clinical trials; therefore, physicians conducting clinical trials must follow a very strict and controlled study plan.